TY - JOUR
T1 - Curcumin potentiates the function of human α 7 -nicotinic acetylcholine receptors expressed in SH-EP1 cells
AU - Nebrisi, Eslam El
AU - Al Kury, Lina T.
AU - Yang, Keun Hang Susan
AU - Jayaprakash, Petrilla
AU - Howarth, Frank C.
AU - Kabbani, Nadine
AU - Oz, Murat
N1 - Funding Information:
The research in this study was supported by grants from CMHS, UAE University and Qatar University . The authors gratefully acknowledge Dr. R Lukas (Barrow Neurological Institute, Phoenix, AZ, USA) for SH-EP1 cells stably expressing the human α 7 nACh and human α 4 β 2 nACh receptor and cordially thank to Dr. Suhail Doi for his valuable help in statistical analysis of the data.
Funding Information:
The research in this study was supported by grants from CMHS, UAE University and Qatar University. The authors gratefully acknowledge Dr. R Lukas (Barrow Neurological Institute, Phoenix, AZ, USA) for SH-EP1 cells stably expressing the human α
Publisher Copyright:
© 2018 Elsevier Ltd
PY - 2018/3
Y1 - 2018/3
N2 - Effects of curcumin, a biologically active ingredient of turmeric, were tested on the Ca 2+ transients induced by the activation of α 7 subunit of the human nicotinic acetylcholine (α 7 nACh) receptor expressed in SH-EP1 cells. Curcumin caused a significant potentiation of choline (1 mM)-induced Ca 2+ transients with an EC 50 value of 133 nM. The potentiating effect of curcumin was not observed in Ca 2+ transients induced by high K + (60 mM) containing solutions or activation of α 4 β 2 nACh receptors and the extent of curcumin potentiation was not altered in the presence of Ca 2+ channel antagonists nifedipine (1 μM), verapamil (1 μM), ω-conotoxin (1 μM), and bepridil (10 μM). Noticeably the effect of curcumin was not observed when curcumin and choline were co-applied without curcumin pre-incubation. The effect of curcumin on choline-induced Ca 2+ transients was not reversed by pre-incubation with inhibitors of protein C, A, and CaM kinases. Metabolites of curcumin such as tetrahydrocurcumin, demethylcurcumin, and didemethylcurcumin also caused potentiation of choline-induced Ca 2+ transients. Notably, specific binding of [ 125 I]-bungarotoxin was not altered in the presence of curcumin. Collectively, our results indicate that curcumin allosterically potentiate the function of the α7-nACh receptor expressed in SH-EP1 cells.
AB - Effects of curcumin, a biologically active ingredient of turmeric, were tested on the Ca 2+ transients induced by the activation of α 7 subunit of the human nicotinic acetylcholine (α 7 nACh) receptor expressed in SH-EP1 cells. Curcumin caused a significant potentiation of choline (1 mM)-induced Ca 2+ transients with an EC 50 value of 133 nM. The potentiating effect of curcumin was not observed in Ca 2+ transients induced by high K + (60 mM) containing solutions or activation of α 4 β 2 nACh receptors and the extent of curcumin potentiation was not altered in the presence of Ca 2+ channel antagonists nifedipine (1 μM), verapamil (1 μM), ω-conotoxin (1 μM), and bepridil (10 μM). Noticeably the effect of curcumin was not observed when curcumin and choline were co-applied without curcumin pre-incubation. The effect of curcumin on choline-induced Ca 2+ transients was not reversed by pre-incubation with inhibitors of protein C, A, and CaM kinases. Metabolites of curcumin such as tetrahydrocurcumin, demethylcurcumin, and didemethylcurcumin also caused potentiation of choline-induced Ca 2+ transients. Notably, specific binding of [ 125 I]-bungarotoxin was not altered in the presence of curcumin. Collectively, our results indicate that curcumin allosterically potentiate the function of the α7-nACh receptor expressed in SH-EP1 cells.
KW - Choline
KW - Curcumin
KW - Intracellular calcium
KW - Nicotinic receptors
UR - http://www.scopus.com/inward/record.url?scp=85041507122&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85041507122&partnerID=8YFLogxK
U2 - 10.1016/j.neuint.2017.12.010
DO - 10.1016/j.neuint.2017.12.010
M3 - Article
C2 - 29341902
AN - SCOPUS:85041507122
SN - 0197-0186
VL - 114
SP - 80
EP - 84
JO - Neurochemistry International
JF - Neurochemistry International
ER -